UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 50

Sortiert nach

HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target

Clinical cancer research, 2018-05, Vol.24 (10), p.2395-2407

2018

Volltextzugriff (PDF)

Tumor cell invasion into Matrigel: optimized protocol for RNA extraction

BioTechniques, 2021-06, Vol.70 (6), p.327-335

2021

Volltextzugriff (PDF)

Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience

Therapeutic advances in medical oncology, 2022, Vol.14, p.175883592211136-17588359221113693

2022

Volltextzugriff (PDF)

PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches

Cancers, 2021-08, Vol.13 (16), p.4040

2021

Volltextzugriff (PDF)

Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy

Cells (Basel, Switzerland), 2020-12, Vol.10 (1), p.14

2020

Volltextzugriff (PDF)

Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target

Frontiers in immunology, 2024-02, Vol.15, p.1356321-1356321

2024

Volltextzugriff (PDF)

Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects

Journal of experimental & clinical cancer research, 2021-11, Vol.40 (1), p.364-364, Article 364

2021

Volltextzugriff (PDF)

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas

Frontiers in oncology, 2018-11, Vol.8, p.526-526

2018

Volltextzugriff (PDF)

Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPG

International journal of molecular sciences, 2020-09, Vol.21 (18), p.6763

2020

Volltextzugriff (PDF)

Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle

Diagnostics (Basel), 2022-08, Vol.12 (9), p.2064

2022

Volltextzugriff (PDF)

HSF1 in Translation

Cancer cell, 2013-08, Vol.24 (2), p.147-149

2013

Volltextzugriff (PDF)

MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression

Frontiers in oncology, 2022-04, Vol.12, p.835642-835642

2022

Volltextzugriff (PDF)

Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects

Journal of experimental & clinical cancer research, 2022-01, Vol.41 (1), p.40-40, Article 40

2022

Volltextzugriff (PDF)

Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas

Cell & bioscience, 2023-11, Vol.13 (1), p.207-207, Article 207

2023

Volltextzugriff (PDF)

Drugging the heat shock factor 1 pathway: Exploitation of the critical cancer cell dependence on the guardian of the proteome

Cell cycle (Georgetown, Tex.), 2009-12, Vol.8 (23), p.3806-3808

2009

Volltextzugriff (PDF)

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant

Neuro-oncology (Charlottesville, Va.), 2022-07, Vol.24 (7), p.1150-1163

2022

Volltextzugriff (PDF)

Abstract B166: A RNA helicase siRNA screen to identify potential therapeutic targets in castration-resistant prostate cancer

Molecular cancer therapeutics, 2015-12, Vol.14 (12_Supplement_2), p.B166-B166

2015

Volltextzugriff (PDF)

Putting the heat on cancer

Nature medicine, 2007-12, Vol.13 (12), p.1415-1417

2007

Volltextzugriff (PDF)

HGG-44. Unraveling and Targeting the stem-regulatory network driving invasion in Diffuse hemispheric glioma, H3G34-mutant

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i71-i71

2022

Volltextzugriff (PDF)

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins

Oncogene, 2015-01, Vol.34 (1), p.15-26

2015

Volltextzugriff (PDF)

HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies

Journal of medicinal chemistry, 2023-04, Vol.66 (8), p.5907-5936

2023

Volltextzugriff (PDF)

Burkitt lymphoma in a patient with Kabuki syndrome carrying a novel KMT2D mutation

American journal of medical genetics. Part A, 2019-01, Vol.179 (1), p.113-117

2019

Volltextzugriff (PDF)

Shock about heat shock in cancer

Oncotarget, 2012-08, Vol.3 (8), p.741-743

2012

Volltextzugriff (PDF)

Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors

Oncogene, 2009-01, Vol.28 (2), p.157-169

2009

Volltextzugriff (PDF)

HGG-43. Abrogation of exosome biogenesis significantly affects cell motility in heterogenous sub-populations of paediatric-type diffuse high-grade glioma

Neuro-oncology (Charlottesville, Va.), 2022-06, Vol.24 (Supplement_1), p.i70-i71

2022

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(45)
Mit Volltextzugriff
(48)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(27)
Life Sciences & Biomedicine
(26)
Humans
(15)
Oncology
(12)
Cancer
(8)
Biochemistry & Molecular Biology
(7)
Cell Biology
(7)
Proteins
(7)
Animals
(6)
Cell Line, Tumor
(6)
Immunotherapy
(6)
Kinases
(5)
Male
(5)
Mice
(5)
Mutation
(5)
Tumors
(5)
Dipg
(4)
Heat Shock Transcription Factors
(4)
Hsp90 Heat-Shock Proteins - Metabolism
(4)
Pediatrics
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HSF1 Is Essential for Myeloma Cell Survival and A Promising Therapeutic Target

Tumor cell invasion into Matrigel: optimized protocol for RNA extraction

Targeted therapy for pediatric diffuse intrinsic pontine glioma: a single-center experience

PI3K/Akt Pathway: The Indestructible Role of a Vintage Target as a Support to the Most Recent Immunotherapeutic Approaches

Manipulating the Metabolism to Improve the Efficacy of CAR T-Cell Immunotherapy

Manipulating the tumor immune microenvironment to improve cancer immunotherapy: IGF1R, a promising target

Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects

BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade Gliomas

Integration of Multiple Platforms for the Analysis of Multifluorescent Marking Technology Applied to Pediatric GBM and DIPG

Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle

HSF1 in Translation

MET Inhibition Sensitizes Rhabdomyosarcoma Cells to NOTCH Signaling Suppression

Correction to: Focal adhesion kinase inhibitor TAE226 combined with Sorafenib slows down hepatocellular carcinoma by multiple epigenetic effects

Inhibition of exosome biogenesis affects cell motility in heterogeneous sub-populations of paediatric-type diffuse high-grade gliomas

Drugging the heat shock factor 1 pathway: Exploitation of the critical cancer cell dependence on the guardian of the proteome

Dual IGF1R/IR inhibitors in combination with GD2-CAR T-cells display a potent anti-tumor activity in diffuse midline glioma H3K27M-mutant

Abstract B166: A RNA helicase siRNA screen to identify potential therapeutic targets in castration-resistant prostate cancer

Putting the heat on cancer

HGG-44. Unraveling and Targeting the stem-regulatory network driving invasion in Diffuse hemispheric glioma, H3G34-mutant

Restricting direct interaction of CDC37 with HSP90 does not compromise chaperoning of client proteins

HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies

Burkitt lymphoma in a patient with Kabuki syndrome carrying a novel KMT2D mutation

Shock about heat shock in cancer

Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors

HGG-43. Abrogation of exosome biogenesis significantly affects cell motility in heterogenous sub-populations of paediatric-type diffuse high-grade glioma

Suchergebnisse filtern